PVH
62
5
RSG
71
3
JWN
48
6
PG
56
5
KEY
46
3
GIS
31
3
IR
66
3
PPL
54
-5
AON
54
2
DHI
48
4
BK
74
2
ISRG
74
-2
KMI
67
-2
MTB
67
2
PRGO
39
3
ROK
62
15
CINF
53
2
VFC
53
5
HPQ
63
6
UNP
52
7
PVH
62
5
RSG
71
3
JWN
48
6
PG
56
5
KEY
46
3
GIS
31
3
IR
66
3
PPL
54
-5
AON
54
2
DHI
48
4
BK
74
2
ISRG
74
-2
KMI
67
-2
MTB
67
2
PRGO
39
3
ROK
62
15
CINF
53
2
VFC
53
5
HPQ
63
6
UNP
52
7
Financhill
Back

Dermata Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
20

DRMA
Dermata Therapeutics

Last Price:
1.11
Seasonality Move:
-52.03%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Sell
20
Dermata Therapeutics (DRMA) is a Sell

Is Dermata Therapeutics a Buy, Sell or Hold?

  • The current Dermata Therapeutics [DRMA] share price is $1.14. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DRMA Stock Price Chart

What is Dermata Therapeutics's stock price today?

  • The Dermata Therapeutics share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

DRMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 21797 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.16 - 1.44) Sell
Bollinger Bands (100): (1.28 - 2.18) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

DRMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.14 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.44 Sell
200-day SMA: 3.36 Sell
8-day EMA: 1.16 Sell
20-day EMA: 1.24 Sell
50-day EMA: 1.44 Sell
200-day EMA: 6.18 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Dermata Therapeutics Earnings Growth & DRMA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Dermata Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):